BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 36200159)

  • 1. Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence.
    Weerasinghe-Mudiyanselage PDE; Kang S; Kim JS; Moon C
    Curr Neuropharmacol; 2023; 21(3):560-577. PubMed ID: 36200159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Changes in Parkinson's Disease Symptoms with and Without Rapid Eye Movement Sleep Behavior Disorder: The Oxford Discovery Cohort Study.
    Liu Y; Lawton MA; Lo C; Bowring F; Klein JC; Querejeta-Coma A; Scotton S; Welch J; Razzaque J; Barber T; Ben-Shlomo Y; Hu MT
    Mov Disord; 2021 Dec; 36(12):2821-2832. PubMed ID: 34448251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of motor and nonmotor symptoms in Parkinson disease for the quality of life: The Japanese Quality-of-Life Survey of Parkinson Disease (JAQPAD) study.
    Kurihara K; Nakagawa R; Ishido M; Yoshinaga Y; Watanabe J; Hayashi Y; Mishima T; Fujioka S; Tsuboi Y
    J Neurol Sci; 2020 Dec; 419():117172. PubMed ID: 33065494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmotor symptoms in Parkinson's disease: expanding the view of Parkinson's disease beyond a pure motor, pure dopaminergic problem.
    Sung VW; Nicholas AP
    Neurol Clin; 2013 Aug; 31(3 Suppl):S1-16. PubMed ID: 23931951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Music Therapy in Parkinson's Disease.
    García-Casares N; Martín-Colom JE; García-Arnés JA
    J Am Med Dir Assoc; 2018 Dec; 19(12):1054-1062. PubMed ID: 30471799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review.
    Yang X; Ma Y; Xie H; Dong S; Rao G; Yang Z; Zhang J; Wu Q
    Curr Med Chem; 2021; 28(31):6375-6394. PubMed ID: 33441061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Syndrome of rapid eye movement sleep behavior disorder and nocturia in Parkinson's disease].
    Nodel MR; Ukraintseva YV; Yakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):15-20. PubMed ID: 29053115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apathy in Parkinson's disease with REM sleep behavior disorder.
    Bargiotas P; Ntafouli M; Lachenmayer ML; Krack P; Schüpbach WMM; Bassetti CLA
    J Neurol Sci; 2019 Apr; 399():194-198. PubMed ID: 30826716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease and REM sleep behavior disorder result in increased non-motor symptoms.
    Neikrug AB; Avanzino JA; Liu L; Maglione JE; Natarajan L; Corey-Bloom J; Palmer BW; Loredo JS; Ancoli-Israel S
    Sleep Med; 2014 Aug; 15(8):959-66. PubMed ID: 24938585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probable rapid eye movement sleep behavior disorder, nocturnal disturbances and quality of life in patients with Parkinson's disease: a case-controlled study using the rapid eye movement sleep behavior disorder screening questionnaire.
    Suzuki K; Miyamoto T; Miyamoto M; Watanabe Y; Suzuki S; Tatsumoto M; Iwanami M; Sada T; Kadowaki T; Numao A; Hashimoto K; Sakuta H; Hirata K
    BMC Neurol; 2013 Feb; 13():18. PubMed ID: 23394437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.
    Scherbaum R; Hartelt E; Kinkel M; Gold R; Muhlack S; Tönges L
    J Neurol; 2020 Apr; 267(4):954-965. PubMed ID: 31797086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease.
    Chaudhuri KR; Hand A; Obam F; Belsey J
    J Med Econ; 2022; 25(1):774-782. PubMed ID: 35593687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.
    Fox SH; Katzenschlager R; Lim SY; Barton B; de Bie RMA; Seppi K; Coelho M; Sampaio C;
    Mov Disord; 2018 Aug; 33(8):1248-1266. PubMed ID: 29570866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
    Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
    Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?
    Crippa JAS; Hallak JEC; Zuardi AW; Guimarães FS; Tumas V; Dos Santos RG
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):121-133. PubMed ID: 30706171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies.
    Deuschl G; Antonini A; Costa J; Śmiłowska K; Berg D; Corvol JC; Fabbrini G; Ferreira J; Foltynie T; Mir P; Schrag A; Seppi K; Taba P; Ruzicka E; Selikhova M; Henschke N; Villanueva G; Moro E
    Mov Disord; 2022 Jul; 37(7):1360-1374. PubMed ID: 35791767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study.
    Kurcova S; Bardon J; Vastik M; Vecerkova M; Frolova M; Hvizdosova L; Nevrly M; Mensikova K; Otruba P; Krahulik D; Kurca E; Sivak S; Zapletalova J; Kanovsky P
    Medicine (Baltimore); 2018 Feb; 97(5):e9750. PubMed ID: 29384860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.